Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

2010108 citationsJournal Articlegold Open Access

Authors

Kathleen Beusterien · Health Outcomes Solutions (United States)

John Davies · Western General Hospital

M.J. Leach · Blood Cancer UK

D. J. Meiklejohn · NHS Tayside

Jessica Grinspan · Health Outcomes Solutions (United States)

Alison O'Toole · Napp Pharmaceuticals (United Kingdom)

Steve Bramham-Jones

Abstract

This study reports UK population utilities for a universal set of CLL health states that incorporate intended treatment response and unintended toxicities. These utilities can be applied in future cost-effectiveness analyses of CLL treatment.

Topics & Keywords

Chronic Lymphocytic Leukemia Research Statistical Methods in Clinical Trials Lymphoma Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Health and Quality of Life Outcomes

Volume 8, Issue 1, pp. 50-50

DOI: 10.1186/1477-7525-8-50

Field-Weighted Citation Impact: 1.25